These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10889192)

  • 1. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).
    Goretzki L; Lombardo CR; Stallcup WB
    J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
    Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
    J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
    Wajih N; Sane DC
    Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of kringle-integrin interaction in plasmin and uPA actions (a hypothesis).
    Takada Y
    J Biomed Biotechnol; 2012; 2012():136302. PubMed ID: 23125522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
    Falcone DJ; Khan KM; Layne T; Fernandes L
    J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
    Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
    Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.
    Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ
    J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
    Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
    Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2.
    Nolin WB; Emmetsberger J; Bukhari N; Zhang Y; Levine JM; Tsirka SE
    Glia; 2008 Jan; 56(2):177-89. PubMed ID: 18000864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.
    Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y
    J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.